Stock Events

Stock Events

Glenmark Pharmaceuticals (GLENMARK.NSE) Q3 2026 Earnings

31JulConfirmed

Q3 2025

Q4 2025

Q1 2026

Q3 2026

1.69

8.32

14.95

21.57

Details

Expected EPS

17.453776932

Actual EPS

17.2620880524

Surprise EPS

-0.19

Surprise Percent

+1.1%

Description

Glenmark Pharmaceuticals (GLENMARK.NSE) has reported earnings of 17.2620880524 per share for Q3 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.